Afriflu2—Second international workshop on influenza vaccination in the African continent—8 November 2012, Cape Town (South Africa)

Highlights • International conference to examine influenza in Africa, Afriflu2. • Significant progress has been made in addressing influenza since Afriflu1 in 2010. • The influenza illness burden is significantly greater in Africa. • Coinfection with HIV, TB and pneumococcus greatly aggravate influe...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2013-08, Vol.31 (35), p.3461-3466
Hauptverfasser:	Schoub, Barry D, Gessner, Bradford D, Ampofo, William, Cohen, Adam L, Steffen, Christoph A
Format:	Artikel
Sprache:	eng
Schlagworte:	Africa Allergy and Immunology Applied microbiology Biological and medical sciences burden of disease Children Coinfection - microbiology Coinfection - virology Conference report Disease Epidemiological Monitoring Fundamental and applied biological sciences. Psychology health care workers Human immunodeficiency virus Humans Illness burden Illnesses Immunization Influenza Influenza Vaccines - therapeutic use Influenza, Human - epidemiology Influenza, Human - immunology Influenza, Human - prevention & control markets Meetings Microbiology monitoring Mortality pandemic Priority groups Public health Streptococcus infections Surveillance Tuberculosis Vaccination Vaccine security Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • International conference to examine influenza in Africa, Afriflu2. • Significant progress has been made in addressing influenza since Afriflu1 in 2010. • The influenza illness burden is significantly greater in Africa. • Coinfection with HIV, TB and pneumococcus greatly aggravate influenza disease. • Indigenous vaccine production is essential for vaccine security for Africa.
ISSN:	0264-410X 1873-2518
DOI:	10.1016/j.vaccine.2013.04.021